LabReady Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

LabReady General Information

Description

Developer of a specimen transport system designed to decrease global infection mortality by making quality testing accessible to everyone. The company's system offers a less expensive and accurate diagnosis of infection by automatically prepping and protecting samples before they are tested, enabling physicians to improve their testing workflow, increase throughput, and deliver faster diagnoses.

Contact Information

Formerly Known As
Vax-Immune
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3718 Sunset Boulevard
  • Suite 301
  • Houston, TX 77005
  • United States
+1 (713)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 3718 Sunset Boulevard
  • Suite 301
  • Houston, TX 77005
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LabReady Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator Completed Generating Revenue
5. Grant 01-Nov-2022 Completed Generating Revenue
4. Seed Round Completed Generating Revenue
3. Seed Round Completed Generating Revenue
2. Accelerator/Incubator 02-Aug-2018 Completed Generating Revenue
1. Grant 01-Sep-2014 $15K Completed Generating Revenue
To view LabReady’s complete valuation and funding history, request access »

LabReady Patents

LabReady Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-218745-S Sample incubation and testing device Active 28-Jun-2022
CA-218746-S Sample incubation and testing device Active 28-Jun-2022
US-D1045121-S1 Sample incubation and testing device Active 28-Jun-2022
US-D1045122-S1 Sample incubation and testing device Active 28-Jun-2022
AU-2016248444-A1 Portable disposable re-usable culture device for rapid diagnosis of infectious agents Active 17-Apr-2015 C12Q1/04
To view LabReady’s complete patent history, request access »

LabReady Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LabReady Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
CSU Starta Corporation Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority
Texas Medical Center Venture Capital Minority
Southwest National Pediatric Device Innovation Consortium Accelerator/Incubator
To view LabReady’s complete investors history, request access »

LabReady FAQs

  • When was LabReady founded?

    LabReady was founded in 2011.

  • Where is LabReady headquartered?

    LabReady is headquartered in Houston, TX.

  • What is the size of LabReady?

    LabReady has 6 total employees.

  • What industry is LabReady in?

    LabReady’s primary industry is Diagnostic Equipment.

  • Is LabReady a private or public company?

    LabReady is a Private company.

  • What is LabReady’s current revenue?

    The current revenue for LabReady is .

  • How much funding has LabReady raised over time?

    LabReady has raised $6M.

  • Who are LabReady’s investors?

    Innovate UK, CSU Starta, Johnson & Johnson Innovation - JLABS, Texas Medical Center, and Southwest National Pediatric Device Innovation Consortium have invested in LabReady.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process